BMY
Bristol-Myers Squibb Company
62.90$
+2.2%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 43.3% | 32.8% | 40.7% | 44.3% | 50.6% | 22.6% | 25.5% | 30.4% | 28.2% | 33.4% | 32.2% | 32.6% | |
| 16.5% | 7.5% | 12.6% | 16.2% | 19.8% | 9.5% | 12.3% | 12.8% | 9.4% | 12.0% | 11.2% | 11.3% | |
| 22.0% | 13.4% | 18.8% | 20.3% | 25.0% | 11.8% | 13.9% | 15.8% | 9.6% | 12.9% | 11.7% | 11.9% | |
| 10.0% | 13.5% | 16.4% | 18.8% | 16.4% | 5.9% | 8.9% | 11.4% | 14.4% | 16.0% | 15.6% | 16.1% | |
| 4.6% | 3.8% | 3.7% | 3.5% | 3.4% | 3.3% | 1.8% | 1.9% | 2.4% | 2.8% | 2.8% | 3.0% | |
| 13.1% | 13.9% | 14.8% | 14.9% | 14.4% | 4.8% | 5.0% | 5.5% | 6.5% | 8.4% | 9.0% | 10.1% | |
| 20.8% | 21.7% | 20.4% | 20.5% | 18.7% | 17.3% | 17.3% | 18.8% | 21.8% | 22.2% | 23.5% | 24.2% | |
| 5.2% | 4.5% | 4.1% | 3.6% | 3.1% | 49.2% | 45.1% | 39.1% | 37.5% | 28.9% | 25.5% | 21.2% | |
| 55.6% | 54.6% | 51.5% | 64.7% | 59.6% | 60.2% | 68.0% | 67.1% | 67.9% | 69.0% | 82.3% | 79.4% | |
| 25.1% | 25.3% | 26.2% | 28.5% | 30.5% | 14.1% | 16.1% | 20.0% | 22.6% | 23.4% | 25.7% | 26.0% | |
| 1.7% | 0.4% | 2.9% | 2.9% | 4.9% | 2.7% | 2.1% | 4.7% | 4.5% | 3.4% | 2.4% | 2.7% | |
| 7.4% | 4.9% | 4.9% | 6.7% | 5.4% | 1.9% | 2.3% | 2.7% | 3.1% | 3.4% | 3.9% | 4.0% | |
| 21.5% | 20.6% | 17.0% | 20.8% | 16.1% | 33.4% | 40.8% | 36.2% | 36.2% | 38.5% | 51.4% | 47.6% | |
| 44.0% | 44.9% | 48.0% | 35.0% | 40.1% | 39.7% | 31.9% | 32.9% | 32.1% | 30.9% | 17.6% | 20.5% | |
| 96.4% | 99.6% | 99.4% | 92.9% | 97.4% | 26.5% | 18.0% | 21.8% | 26.3% | 30.2% | 16.1% | 18.8% | |
| 4.9% | 5.3% | 5.0% | 4.9% | 4.7% | 1.3% | 1.9% | 2.1% | 2.2% | 2.2% | 2.2% | 2.3% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.